• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes

Recent Advances in the Study of 2-(2-propynyloxy)-1-naphthaldehyde (CAS: 58758-48-8) in Chemical Biology and Pharmaceutical Research

The compound 2-(2-propynyloxy)-1-naphthaldehyde (CAS: 58758-48-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug discovery and development. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, including its synthesis, biological activities, and potential therapeutic applications. The information presented herein is based on a thorough review of recent academic literature, industry reports, and technical documents.

Recent studies have highlighted the versatility of 2-(2-propynyloxy)-1-naphthaldehyde as a key intermediate in the synthesis of various bioactive molecules. Its naphthalene core and propargyl ether moiety make it an attractive scaffold for the development of novel inhibitors targeting enzymes such as kinases and proteases. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in inhibiting the activity of cyclin-dependent kinases (CDKs), which are critical regulators of cell cycle progression and are often dysregulated in cancer.

In addition to its role as a kinase inhibitor, 2-(2-propynyloxy)-1-naphthaldehyde has shown promise in the development of fluorescent probes for bioimaging applications. A recent study in Analytical Chemistry reported the synthesis of a derivative of this compound that exhibits strong fluorescence properties, making it suitable for real-time monitoring of cellular processes. This application is particularly relevant in the study of neurodegenerative diseases, where the ability to track molecular interactions in live cells is crucial for understanding disease mechanisms.

The synthetic pathways for 2-(2-propynyloxy)-1-naphthaldehyde have also been optimized in recent years, with researchers developing more efficient and environmentally friendly methods. A 2022 publication in Organic Process Research & Development described a novel catalytic approach that reduces the need for hazardous reagents and minimizes waste production. These advancements not only improve the scalability of the compound's production but also align with the growing emphasis on sustainable chemistry in the pharmaceutical industry.

Despite these promising developments, challenges remain in the clinical translation of 2-(2-propynyloxy)-1-naphthaldehyde-based therapeutics. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through further preclinical and clinical studies. However, the compound's demonstrated versatility and the ongoing research efforts suggest that it holds significant potential for future drug development and chemical biology applications.

In conclusion, 2-(2-propynyloxy)-1-naphthaldehyde (CAS: 58758-48-8) represents a valuable tool in the arsenal of chemical biologists and pharmaceutical researchers. Its diverse applications, ranging from kinase inhibition to bioimaging, underscore its importance in advancing our understanding of disease mechanisms and developing novel therapeutic strategies. Continued research into its properties and applications is expected to yield further insights and innovations in the coming years.

• 29978-83-4(2-(2-Propynyloxy)benzenecarbaldehyde)
• 19523-57-0(2-ethoxynaphthalene-1-carbaldehyde)
• 885-26-7(2-propoxynaphthalene-1-carbaldehyde)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)